Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Apply
Pembrolizumab, Gemcitabine, Cisplatin
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step